Patents by Inventor Joann Witek

Joann Witek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acids coding for antibodies against human IL-21 receptor and uses therefor
    Patent number: 8143385
    Abstract: The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The antibodies can act as antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders.
    Type: Grant
    Filed: January 14, 2009
    Date of Patent: March 27, 2012
    Assignees: Wyeth LLC, MedImmune Ltd.
    Inventors: Viia Valge-Archer, Andrew James Williams, Deborah A. Young, Matthew J. Whitters, Mary Collins, Joann Witek
  • ANTIBODIES AGAINST HUMAN IL-21 RECEPTOR AND USES THEREFOR
    Publication number: 20100297151
    Abstract: The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The antibodies can act as antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders.
    Type: Application
    Filed: January 14, 2009
    Publication date: November 25, 2010
    Applicants: WYETH, CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
    Inventors: Viia Valge-Archer, Andrew James Williams, Deborah A. Young, Matthew J. Whitters, Mary Collins, Joann Witek
  • Antibodies against human or mouse IL-21 receptor
    Patent number: 7495085
    Abstract: The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The antibodies can act as antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: February 24, 2009
    Assignees: Wyeth, Cambridge Antibody Technology Limited
    Inventors: Viia Valge-Archer, Andrew James Williams, Deborah A. Young, Matthew J. Whitters, Mary Collins, Joann Witek
  • Antibodies against human IL-21 receptor and uses therefor
    Publication number: 20040265960
    Abstract: The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The antibodies can act as antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders.
    Type: Application
    Filed: March 12, 2004
    Publication date: December 30, 2004
    Applicants: Wyeth, Cambridge Antibody Technology Limited
    Inventors: Viia Valge-Archer, Andrew James Williams, Deborah A. Young, Matthew J. Whitters, Mary Collins, Joann Witek